Bu həftə 0 qeyd
0
Sosial
Xəbərlər
Bloq
Moderna and Merck cancer vaccine cuts melanoma recurrence by 44% in late-stage trial
6g əvvəl
Moderna and Merck vaccine cuts melanoma recurrence risk by 44% in phase 3 study
